Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Fulton DuncanChief Corporate Officer | Grant or award | A | — 221 sh | Jan 8, 2026 |
| 5 | Perdue PeterPresident, Popeyes-US & Canada | Grant or award | A | — 5 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 5 | Perdue PeterPresident, Popeyes-US & Canada | Grant or award | A | — 111 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 5 | Housman JeffreySee Remarks | Grant or award | A | — 225 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 5 | Housman JeffreySee Remarks | Grant or award | A | — 49 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 5 | Fulton DuncanChief Corporate Officer | Grant or award | A | — 196 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 4 | Dines DanielDirector, CEO and Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $787K 45.0K sh | Jan 8, 2026 traded Jan 8, 2026 |
| 3 | Schlosser MarioDirector, President of Technology & CTO | Derivative conversion · 10b5-1 plan | C | — 77.0K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 2 | Flammer Martina M.D.Chief Medical Officer | Option exercise · 10b5-1 plan | M | $227K 8,570 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 1 | Scaringe Robert JDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $2,009 100 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 0 | Choudary Kiran KumarChief Financial Officer | Derivative conversion · 10b5-1 plan | C | — 2,000 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 0 | Biswas SanjitDirector, CHIEF EXECUTVE OFFICER, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 100.0K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 0 | Bicket JohnDirector, SEE REMARKS, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 430.0K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 0 | Wren ChrisVP of Operations | Open-market sale · 10b5-1 plan | SELL | $6,066 30.0K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | Derivative conversion · 10b5-1 plan | C | — 154.5K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 0 | Biswas SanjitDirector, CHIEF EXECUTVE OFFICER, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 100.0K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 0 | Bicket JohnDirector, SEE REMARKS, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 100.0K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 0 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 52.4K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 0 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 52.4K sh | Jan 8, 2026 traded Jan 8, 2026 |
| 0 | Bicket JohnDirector, SEE REMARKS, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 430.0K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 0 | Biswas SanjitDirector, CHIEF EXECUTVE OFFICER, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 430.0K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 0 | Biswas SanjitDirector, CHIEF EXECUTVE OFFICER, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 1.97M sh | Jan 8, 2026 traded Jan 6, 2026 |
| 0 | Venturo Brian MDirector, Chief Strategy Officer | Derivative conversion · 10b5-1 plan | C | — 154.5K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 0 | Choudary Kiran KumarChief Financial Officer | Option exercise · 10b5-1 plan | M | — 2,000 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 0 | Choudary Kiran KumarChief Financial Officer | Derivative conversion · 10b5-1 plan | C | — 2,000 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 0 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 52.4K sh | Jan 8, 2026 traded Jan 7, 2026 |
| 0 | Biswas SanjitDirector, CHIEF EXECUTVE OFFICER, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 1.97M sh | Jan 8, 2026 traded Jan 6, 2026 |
| 0 | Flammer Martina M.D.Chief Medical Officer | Option exercise · 10b5-1 plan | M | — 8,570 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 0 | Bicket JohnDirector, SEE REMARKS, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 1.97M sh | Jan 8, 2026 traded Jan 6, 2026 |
| 0 | Bicket JohnDirector, SEE REMARKS, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 100.0K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 0 | Bicket JohnDirector, SEE REMARKS, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 1.97M sh | Jan 8, 2026 traded Jan 6, 2026 |
| 0 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 52.4K sh | Jan 8, 2026 traded Jan 8, 2026 |
| 0 | Schlosser MarioDirector, President of Technology & CTO | Derivative conversion · 10b5-1 plan | C | — 77.0K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 0 | Choudary Kiran KumarChief Financial Officer | Option exercise · 10b5-1 plan | M | — 2,000 sh | Jan 8, 2026 traded Jan 7, 2026 |
| 0 | Biswas SanjitDirector, CHIEF EXECUTVE OFFICER, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 430.0K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 0 | Peterson Neil W.CHIEF OPERATING OFFICER | Option exercise · 10b5-1 plan | M | — 5,000 sh | Jan 8, 2026 traded Jan 6, 2026 |
| 0 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 52.4K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 0 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 52.4K sh | Jan 8, 2026 traded Jan 6, 2026 |
| 49 | Tenev VladimirDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $17.97M 146.8K sh | Jan 7, 2026 traded Jan 5, 2026 |
| 47 | Clapp Steven BDirector | Open-market sale | SELL | $4.05M 170.5K sh | Jan 7, 2026 traded Jan 5, 2026 |